[{"orgOrder":0,"company":"Omikron Italia","sponsor":"OPIS Spain","pharmaFlowCategory":"DU","therapeuticArea":"Ophthalmology","country":"ITALY","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Ophthalmology","graph2":"Phase III","graph3":"Omikron Italia","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Ophthalmology","amount2New":0,"dosageForm":"Ophthalmic Solution","sponsorNew":"Omikron Italia \/ OPIS Spain","highestDevelopmentStatusID":"10","companyTruncated":"Omikron Italia \/ OPIS Spain"},{"orgOrder":0,"company":"Kirin Holdings Company, Limited","sponsor":"Biofortis Clinical Research, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Citicoline Sodium","moa":"LicC protein","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kirin Holdings Company, Limited","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kirin Holdings Company, Limited \/ Biofortis Clinical Research, Inc.","highestDevelopmentStatusID":"1","companyTruncated":"Kirin Holdings Company, Limited \/ Biofortis Clinical Research, Inc."}]

Find Clinical Drug Pipeline Developments & Deals for Citicoline Sodium

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Pharmaconex
                          Not Confirmed
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          February 02, 2023

                          Lead Product(s) : Citicoline Sodium

                          Therapeutic Area : Ophthalmology

                          Highest Development Status : Phase III

                          Sponsor : OPIS Spain

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Kirin Holdings Company, Limited

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Kirin Holdings Company, Limited

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          July 19, 2021

                          Lead Product(s) : Citicoline Sodium

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Biofortis Clinical Research, Inc.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Pharmaconex
                          Not Confirmed
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          February 23, 2018

                          Lead Product(s) : Citicoline Sodium

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Oregon Health and Science University

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Pharmaconex
                          Not Confirmed
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          December 12, 2017

                          Lead Product(s) : Citicoline Sodium

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : Biofortis Clinical Research, Inc.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          VivaTech International, Inc.

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          VivaTech International, Inc.

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          July 26, 2016

                          Lead Product(s) : Citicoline Sodium

                          Therapeutic Area : Musculoskeletal

                          Highest Development Status : Phase II

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          VivaTech International, Inc.

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          VivaTech International, Inc.

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          July 26, 2016

                          Lead Product(s) : Citicoline Sodium

                          Therapeutic Area : Musculoskeletal

                          Highest Development Status : Phase II

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          VivaTech International, Inc.

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          VivaTech International, Inc.

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          July 26, 2016

                          Lead Product(s) : Citicoline Sodium

                          Therapeutic Area : Musculoskeletal

                          Highest Development Status : Phase II

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          Pharmaconex
                          Not Confirmed
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          March 10, 2016

                          Lead Product(s) : Citicoline Sodium

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Undisclosed

                          Sponsor : University of Cincinnati

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          Centre Hospitalier Universitaire de Nice

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Centre Hospitalier Universitaire de Nice

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          April 19, 2011

                          Lead Product(s) : Citicoline Sodium

                          Therapeutic Area : Oncology

                          Highest Development Status : Undisclosed

                          Sponsor : DENSMORE pharmaceuticals

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank